Timothy E. Albertson, MD, MPH, PhD

Department of Internal Medicine, University of California, Davis, School of Medicine, Sacramento, CA, USA

Dr. Timothy E Albertson is the Chair of Internal Medicine at the University of California, Davis, School of Medicine. Prior to this position, he was Chief of Pulmonary and Critical Care Medicine at UC Davis. He has also been a faculty trainer for more than 10 years. Dr Albertson has had a long-standing interest in both clinical and research in the toxicology of clinical drugs of abuse including their epidemiology. He has a long-standing interest in clinical trials related to sepsis and ARDS. His research has ranged from basic pharmacological and toxicological studies exploring nervous system plasticity to clinical trials on sepsis and ARDS. ARDS clinical research has provided opportunities for residents, fellows and PhD students to have experience with NIH-funded and industry-funded clinical research. He frequently mentors junior faculty in establishing their research early in their academic careers. Dr Albertson has contributed significantly to the advancement of our understanding of clinical toxicology. This research focuses on translational projects with immediate application to patient care including clinical pharmacology/drug trials, clinical poisonings, critical care/ventilator management, sepsis, and septic shock. Dr Albertson’s training, as a physician scientist and as a basic scientist, especially in pharmacokinetics and environmental areas, provides an excellent basis for participating in training new lung biologists. He is directly involved in graduate teaching of Pharmacology and Toxicology in the Graduate Group. His current research efforts combine his training in pharmacology and toxicology, patient care and clinical medicine. Dr Albertson’s academic responsibility continues to focus on environmental health and lung pathophysiology. In addition, because of his clinical association with the CTSC and his academic administrative position, he remains a key faculty trainer to bridge the clinical translational research and basic pulmonary pharmaco-physiology.